PAIN Vector Science and Therapeutics Corp.

1.769USD2.530 CAD · TSXV-1.17%Mkt Cap: 9.73M USDP/E: —

Vector Science and Therapeutics Corp. develops precision biomechanical devices and active transdermal delivery systems for musculoskeletal regeneration. The company offers cGMP-manufactured Rx peptides for physicians and…

Key Statistics

Company
Market Cap9.73M USD
Enterprise Value275.72M USD
Revenue (TTM)—
Gross Profit-150.05K USD
Net Income (TTM)-898.01K USD
Revenue/Share—
Last Price1.769 USD
Fiscal Year EndAug 2025
MR QuarterMay 2026
Employees—
CountryCA
SectorHealthcare
IndustryMedical Devices
ISINCA92244M1041
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B138.58
EPS (TTM)-0.01 USD
EPS (Forward)—
52W Range
0.244776% of range2.258
52W High2.258 USD
52W Low0.2447 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-52.07%
ROA-29.88%
ROIC—
ROCE-29.92%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-773.78K USD
CapEx (TTM)23.47K USD
FCF Margin—
FCF Yield—
Net Debt-1.17M USD
Net Debt/EBITDA—
Net Debt/FCF—
Balance Sheet
Debt/Equity—
Current Ratio11.81
Quick Ratio11.41
Book Value/Sh0.02 USD
Cash/Share0.0070 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.5.50M
Float134.27M
Insiders24.28%
Institutions0.00%
Short Interest
Short Ratio2.3d
Short % Out.0.14%
Shares Short223.91K
Short (prev mo.)273.62K
Technical
SMA 501.351 (+30.9%)
SMA 2001.249 (+41.6%)
Beta4.76
S&P 52W Chg12.00%
Avg Vol (30d)111.94K
Avg Vol (10d)164.35K
Technical Indicators
RSI (14)59.0
MACD0.2685
MACD Signal0.2132
MACD Hist.+0.0553
BB Upper2.223 USD
BB Middle1.544 USD
BB Lower0.8658 USD
BB Width87.86%
ATR (14)0.1613 USD
Vol Ratio (20d)1.36x

About Vector Science and Therapeutics (CVE: PAIN)

›

Vector Science and Therapeutics (CVE: PAIN) is listed on the TSX Venture Exchange, where its shares trade in CAD. It belongs to the Medical Devices industry, part of the Healthcare sector.

The shares were at 2.530 CAD on 19 November 2026. Its 52-week range is 0.3500 CAD to 3.230 CAD: the price is 21.7% below the high and 622.9% above the low.

Its market capitalisation is 13.91M CAD.

Vector Science and Therapeutics reports return on equity of -52.1% and an operating margin of 0.0%.

It holds more cash than debt, a net cash position of 1.17M USD. Its Piotroski F-score is 2 out of 9, a weak reading of its financial health.